Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
Clinical trial NCT00005635 · COMPLETED
Trial details
- NCT number
- NCT00005635
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-01-01
- Primary completion
- 2001-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.